Anti-CD79B/ AGM6/ B29 monoclonal antibody

Anti-CD79B/ AGM6/ B29 antibody for FACS & in-vivo assay

Target products collectionGo to CD79B/CD79B products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T08306-Ab-1/ GM-Tg-hg-T08306-Ab-2Anti-Human CD79B monoclonal antibodyHuman
GM-Tg-rg-T08306-Ab-1/ GM-Tg-rg-T08306-Ab-2Anti-Rat CD79B monoclonal antibodyRat
GM-Tg-mg-T08306-Ab-1/ GM-Tg-mg-T08306-Ab-2Anti-Mouse CD79B monoclonal antibodyMouse
GM-Tg-cynog-T08306-Ab-1/ GM-Tg-cynog-T08306-Ab-2Anti-Cynomolgus/ Rhesus macaque CD79B monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T08306-Ab-1/ GM-Tg-felg-T08306-Ab-2Anti-Feline CD79B monoclonal antibodyFeline
GM-Tg-cang-T08306-Ab-1/ GM-Tg-cang-T08306-Ab-2Anti-Canine CD79B monoclonal antibodyCanine
GM-Tg-bovg-T08306-Ab-1/ GM-Tg-bovg-T08306-Ab-2Anti-Bovine CD79B monoclonal antibodyBovine
GM-Tg-equg-T08306-Ab-1/ GM-Tg-equg-T08306-Ab-2Anti-Equine CD79B monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg

Product Description

Catalog No.GM-Tg-hg-T08306-Ab-1/ GM-Tg-hg-T08306-Ab-2; GM-Tg-rg-T08306-Ab-1/ GM-Tg-rg-T08306-Ab-2;
GM-Tg-mg-T08306-Ab-1/ GM-Tg-mg-T08306-Ab-2; GM-Tg-cynog-T08306-Ab-1/ GM-Tg-cynog-T08306-Ab-2;
GM-Tg-felg-T08306-Ab-1/ GM-Tg-felg-T08306-Ab-2; GM-Tg-cang-T08306-Ab-1/ GM-Tg-cang-T08306-Ab-2;
GM-Tg-bovg-T08306-Ab-1/ GM-Tg-bovg-T08306-Ab-2; GM-Tg-equg-T08306-Ab-1/ GM-Tg-equg-T08306-Ab-2
Products NameAnti-CD79B monoclonal antibody
Target NameCD79B
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody, Therapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
Products descriptionPre-made anti-CD79B benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


    Data / case study

    Click to get more Data / Case study about the product.

    Associated products

    CategoryCat No.Products Name
    BiosimilarGMP-Bios-INN-962Pre-Made Polatuzumab Vedotin Biosimilar, Whole Mab Adc, Anti-Cd79B Antibody: Anti-AGM6/B29/IGB therapeutic antibody Drug Conjugate
    BiosimilarGMP-Bios-INN-862Pre-Made Iladatuzumab Vedotin Biosimilar, Whole Mab Adc, Anti-Cd79B Antibody: Anti-AGM6/B29/IGB therapeutic antibody Drug Conjugate
    BiosimilarGMP-Bios-ab-264Pre-Made Iladatuzumab biosimilar, Whole mAb ADC, Anti-CD79B Antibody: Anti-AGM6/B29/IGB therapeutic antibody
    BiosimilarGMP-Bios-ab-449Pre-Made Polatuzumab biosimilar, Whole mAb ADC, Anti-CD79B Antibody: Anti-AGM6/B29/IGB therapeutic antibody
    Target AntigenProducts DevelopingMulti-species CD79B/ AGM6/ B29 VLP (virus-like particle) (Products Developing)
    ORF Viral VectorvGMLP000751human CD79B Lentivirus particle
    ORF Viral VectorpGMLP000751human CD79B Lentivirus plasmid

    Target information

    Target IDGM-T08306
    Target NameCD79B
    Gene ID974,15985,171055,718218,609449,101098098,509801,100064460
    Gene Symbol and SynonymsAGM6,B29,CD79B,Ig-beta,IGB,Igbeta
    Uniprot AccessionP40259
    Uniprot Entry NameCD79B_HUMAN
    Protein Sub-locationTransmembrane Protein
    CategoryTherapeutics Target, INN Index
    Gene EnsemblENSG00000007312
    Target ClassificationTumor-associated antigen (TAA)

    The target: CD79B, gene name: CD79B, also named as AGM6, B29, IGB. The B lymphocyte antigen receptor is a multimeric complex that includes the antigen-specific component, surface immunoglobulin (Ig). Surface Ig non-covalently associates with two other proteins, Ig-alpha and Ig-beta, which are necessary for expression and function of the B-cell antigen receptor. This gene encodes the Ig-beta protein of the B-cell antigen component. Alternatively spliced transcript variants encoding different isoforms have been described. [provided by RefSeq, Jul 2008].

    About Gmab


    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.